Immune disease and HLA associations with myasthenia gravis.
Open Access
- 1 July 1980
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 43 (7) , 611-621
- https://doi.org/10.1136/jnnp.43.7.611
Abstract
In the late 1950's laboratory and clinical evidence suggested that myasthenia gravis was an autoimmune disorder. Since then a voluminous literature has developed documenting the many immunological abnormalities that occur in this condition. Recent findings point to a central disorder of immunoregulation. It is postulated that the disease occurs as a result of host genetic and environmental influences-the latter being, as yet unidentified and possibly a virus.Keywords
This publication has 90 references indexed in Scilit:
- Abnormalities of Immunoregulatory T Cells in Disorders of Immune FunctionNew England Journal of Medicine, 1979
- Identification of Two Serum Components Regulating the Expression of T-Lymphocyte Function in Childhood Myasthenia GravisNew England Journal of Medicine, 1979
- Lymphocyte function in myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1979
- Immune complexes in myasthenia gravisJournal of Neurology, Neurosurgery & Psychiatry, 1979
- Thymic lymphocytes in myasthenia gravisAnnals of Neurology, 1977
- Myasthenia GravisNew England Journal of Medicine, 1977
- Anti-Acetylcholine Receptor Antibody in Neonatal Myasthenia GravisNew England Journal of Medicine, 1977
- No Evidence That Botulism Causes Sudden Infant DeathsNew England Journal of Medicine, 1977
- DECREASED SERUM-IgA IN MYASTHENIA GRAVISThe Lancet, 1976
- Increased survival of NZBW mice given multiple syngeneic young thymus graftsClinical Immunology and Immunopathology, 1973